Form 4: VolitionRx Director Timothy Still Acquires 87,382 Shares in Direct Offering

Director Timothy Still acquired 87,382 shares of VolitionRx common stock at $0.5722 per share through a registered direct offering.

Summary

• Timothy Still, a director at VolitionRx, acquired 87,382 shares of common stock.
• The shares were purchased at a price of $0.5722 each.
• This transaction occurred on December 9, 2024.
• The acquisition was part of a registered direct offering by VolitionRx.
• Following the transaction, Mr. Still directly owns 1,487,382 shares of VolitionRx.

Sentiment

Score: 6

Explanation: The document is neutral, detailing a routine insider transaction. The director's purchase could be seen as a positive sign, but it's not a major event.

Positives

• A director's purchase of shares can be seen as a positive sign of confidence in the company's future.
• The direct offering provides capital to the company.

Industry Context

This transaction is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company directors.

Comparison to Industry Standards

• Direct offerings are a common method for companies to raise capital, and insider purchases are a normal part of the market.
• The size of the purchase is not unusual for a director of a company of this size.
• Comparable companies often see similar insider transactions, which are closely monitored by investors.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's purchase.

Key Dates

Keywords

VolitionRx, VNRX, Timothy Still, direct offering, share acquisition, insider trading, common stock